Embecta (FRA:JX7) Beginning Cash Position : €275 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Embecta Beginning Cash Position?

Embecta's Beginning Cash Position for the quarter that ended in Mar. 2024 was €275 Mil.

Embecta's quarterly Beginning Cash Position increased from Sep. 2023 (€297 Mil) to Dec. 2023 (€299 Mil) but then declined from Dec. 2023 (€299 Mil) to Mar. 2024 (€275 Mil).

Embecta's annual Beginning Cash Position increased from Sep. 2021 (€0 Mil) to Sep. 2022 (€0 Mil) and increased from Sep. 2022 (€0 Mil) to Sep. 2023 (€310 Mil).

Embecta Beginning Cash Position Historical Data

The historical data trend for Embecta's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Beginning Cash Position Chart

Embecta Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Beginning Cash Position

310.05

Embecta Quarterly Data
	Sep19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial											359.78	319.73	297.40	299.40	274.80

Embecta Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Embecta Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Embecta's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Embecta (FRA:JX7) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

EMBC:USA JX7:Germany

Address

300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054

Website

https://www.embecta.com

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Embecta (FRA:JX7) Headlines

No Headlines